• About
  • Keywords

Toxoplasma gondii & Human Phenotype

Compendium of Known Effects and Ongoing Research

pyrimethamine

Toxoplasma gondii and male reproduction impairment: A new aspect of toxoplasmosis research

October 10, 2013
Dalimi A, Abdoli A.
Jundishapur Journal of Microbiology 2013; 6.
Click for abstract
Introduction: Toxoplasma gondii is one of the most important pathogen that has adverse effect on reproductive function. Evidence Acquisition: Recent studies revealed that infection with T. gondii not only affect female reproduction, also cause male reproductive impairment. In clinical studies, high prevalence of toxoplasmosis in sterile men has been reported. In animal models, toxoplasmosis is associated with male reproductive impairment. Moreover, there are some evidences about venereal transmission of T. gondii. Drugs used for treatment of toxoplasmosis may cause adverse effects on male reproductive function. Results: In present article, effect of Toxoplasma infection on male reproductive system of human and animal was reviewed. There are several reports expressing association between Toxoplasmosis and male genital tract impairment in both human and animals. Conclusions: These findings suggest that T. gondii infection can cause temporary impairment on the reproductive parameters of human or animal male as well as impairment of different hormones which may cause insufficient male reproductivity.

Tagged: acquired-immunodeficiency-syndrome, congenital toxoplasmosis, human spermatogenesis, hypogonadotropic hypogonadism, infection, male rats, male-infertility, murine toxoplasmosis, pyrimethamine, reproductive function, semen, sterility, Toxoplasma gondii

Physical healthReproduction

Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii ‘s ability to alter host behaviour

October 30, 2006
Webster, J.P., Lamberton, P.H.L., Donnelly, C.A., Torrey, E.F.
Proceedings of the Royal Society B-Biological Sciences 2006; 273: 1023-1030
Click for abstract
With increasing pressure to understand transmissible agents, renewed recognition of infectious causation of both acute and chronic diseases is occurring. Epidemiological and neuropathological studies indicate that some cases of schizophrenia may be associated with environmental factors, such as exposure to the ubiquitous protozoan Toxoplasma gondii. Reasons for this include T gondii's ability to establish persistent infection within the central nervous system, its ability to manipulate intermediate host behaviour, the occurrence of neurological and psychiatric symptoms in some infected individuals, and an association between infection with increased incidence of schizophrenia. Moreover, several of the medications used to treat schizophrenia and other psychiatric disease have recently been demonstrated in vitro to possess antiparasitic, and in particular anti-T gondii, properties. Our aim here was thus to test the hypothesis that the anti-psychotic and mood stabilizing activity of some medications may be achieved, or at least augmented, through their in vivo inhibition of T gondii replication and invasion in infected individuals. In particular we predicted, using the epidemiologically and clinically applicable rat-T gondii model system, and following a previously described and neurologically characterized 'feline attraction' protocol that haloperidol (an antipsychotic used in the treatment of mental illnesses including schizophrenia) and/or valproic acid (a mood stabilizer used in the treatment of mental illnesses including schizophrenia), would be, at least, as effective in preventing the development of T gondii-associated behavioural and cognitive alterations as the standard anti-T gondii chemotherapeutics pyrimethamine with Dapsone. We demonstrate that, while T gondii appears to alter the rats' perception of predation risk turning their innate aversion into a 'suicidal' feline attraction, anti-psychotic drugs prove as efficient as anti-T gondii drugs in preventing such behavioural alterations. Our results have important implications regarding the aetiology and treatment of such disorders.

Tagged: acquired toxoplasmosis, antibodies, brain, cat odor, dapsone, Dopamine, infection, medication, parasite-altered behaviour, pyrimethamine, rattus-norvegicus, Schizophrenia, Toxoplasma gondii

BehaviorMental health

Topics

  • Behavior 105
  • Cognitive functions 64
  • Mental health 439
  • Morphology 6
  • Motor functions 10
  • Personality 36
  • Physical health 134
  • Reproduction 36
  • Reviews 40
  • Sensory functions 3
  • Uncategorized 2

Archives

Recent articles

  • Mortality Patterns of Toxoplasmosis and Its Comorbidities in Tanzania: A 10-Year Retrospective Hospital-Based Survey February 6, 2020
  • The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia–the risk factor or an indication of a contact with cat? February 6, 2020
  • The Association between Toxoplasma gondii Infection and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis February 6, 2020

Recent Comments

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Copyright © 2023 Toxoplasma gondii & Human Phenotype.

    ToxoBehavior WordPress Theme by Jelena Braum